ArticleClinical and translational medicine2023

Predictive value of DOT1L mutations for clinical outcomes in non-small-cell lung cancer patients receiving immune checkpoint inhibitor therapy.

Tianxing Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.